Detailed price information for Impedimed Ltd Ord (IPDQF) from The Globe and Mail including charting and trades.

Impedimed Limited ( (AU:IPD) ) just unveiled an update.

We can readily understand why investors are attracted to unprofitable companies. By way of example, ImpediMed (ASX:IPD) has seen its share price rise 243% over the last year, delighting many ...

As every investor would know, you don't hit a homerun every time you swing. But it's not unreasonable to try to avoid truly shocking capital losses. So we hope that those who held ImpediMed Limited ...

There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although software-as-a-service business Salesforce.com lost money for years while it grew recurring ...

ImpediMed Limited (ASX: IPD) (OTCPK: IPDQF) has just seen its stock price double, up 100% on the day. The cause is that the recommended treatment guidelines now include the use of the ImpediMed ...

Medical device maker ImpediMed is promoting lymphedema awareness, testing and early detection in its first consumer campaign, "Lymphedema Can't." (ImpediMed) () Imagine surviving cancer and then ...

ImpediMed Limited (ASX: IPD), a global provider of medical technology to measure, monitor and manage fluid status in patients, has announced the U.S. commercial launch of its L-Dex ® system to aid in ...

Former Hologic executive brings nearly two decades of success in hospital sales and commercialization expertise to medical technology leader's board CARLSBAD, Calif., Feb. 25, 2026 /PRNewswire/ -- ...

CARLSBAD, Calif. & BRISBANE, Australia--(BUSINESS WIRE)--ImpediMed Limited (ASX:IPD), a global provider of medical technology to non-invasively measure, monitor and manage tissue composition and fluid ...

CARLSBAD, Calif., April 7, 2026 /PRNewswire/ -- ImpediMed, a leader in the development and commercialization of medical technologies to clinically monitor and manage fluid and body composition, and ...

AstraZeneca has extended a contract to use a digital health device developed by ImpediMed that is being deployed in a trial of two of its drugs in chronic kidney disease (CKD). The SOZO device can ...